(Q44558546)

4 December 2017

title

Exacerbation of psoriasis by thalidomide in Behçet's syndrome (English)

1 reference

4 December 2017

0 references

0 references

1

Dobson CM

1 reference

4 December 2017

Parslew RA

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

British Journal of Dermatology

4 December 2017

published in

1 reference

4 December 2017

volume

149

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

432-433

1 reference

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Thalidomide in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Thalidomide in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Immune stimulation in scleroderma patients treated with thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05449.X

10.1046/J.1365-2133.2003.05449.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference